Pick Disease of the Brain: all 104 studies
Page 1 of 2. Open to participants first (32), then studies with results posted, then the rest; newest registration first within each.
- Ultra-high-performance Positron Emission Tomography (PET) of Synaptic Density, Reactive Astrogliosis and Tau in Alzheimer's DiseaseNot yet recruitingNCT07906054
- A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Primary TauopathiesNot yet recruitingNCT07868328Phase 2
- Restoring Cervical Lymphatic Drainage in Alzheimer's DiseaseRecruitingNCT07854327Not applicable
- Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative DiseasesRecruitingNCT07531732
- A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear PalsyRecruitingNCT07498426Phase 3
- Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.Enrolling by invitationNCT07234851
- Learning Amyloid and Tau ResultsEnrolling by invitationNCT07222930
- Daridorexant for Alzheimer Disease PreventionRecruitingNCT07213349Phase 2
- Alzheimer's Tau Platform: Regimen A - AADvac1Enrolling by invitationNCT07167966Phase 2
- Investigator Initiated Study for the Safety and Efficacy in Frontotemporal DementiaNot yet recruitingNCT07154485Phase 2
- A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.RecruitingNCT06823752Phase 2
- A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated ApproachRecruitingNCT06706687Not applicable
- Tau PET/CT in Various Tau-Related Disease PatientsRecruitingNCT06690983
- Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive ImpairmentRecruitingNCT06618872Not applicable
- Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal DementiaRecruitingNCT06604520Phase 2
- The Skin as a Window to the Central Nervous System in Frontotempolar Lombar DegenerationRecruitingNCT06490822Not applicable
- A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's DiseaseRecruitingNCT06297590Phase 1
- Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)Enrolling by invitationNCT05967390
- Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?RecruitingNCT05943925
- Multifactorial Approach to Dementia, Multicentric StudyRecruitingNCT05923307
- The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)RecruitingNCT05885295
- Alzheimer's Disease Neuroimaging Initiative 4Enrolling by invitationNCT05617014
- BioFINDER-Brown: Examination of Alzheimer's Disease BiomarkersEnrolling by invitationNCT05457998
- Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and EmotionsRecruitingNCT05165186Not applicable
- Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease DiagnosisRecruitingNCT05020626
- Semantic Rehabilitation for Patients With Primary Progressive Semantic AphasiaRecruitingNCT04957537Not applicable
- Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related DisordersEnrolling by invitationNCT04680130
- Study of Tau Imaging With the Use of [18F]MK-6240 TracerEnrolling by invitationNCT04104659
- Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.Enrolling by invitationNCT03389100Phase 2
- Tau PET in Imaging and Cognition: Healthy Adults From 55-90RecruitingNCT03372317
- The Swedish BioFINDER 2 StudyRecruitingNCT03174938Not applicable
- Modifiable Variables in Parkinsonism (MVP)RecruitingNCT02194816
- A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's DiseaseCompletedNCT05063539Phase 2Results posted
- Improving Self-Care of Behavioral Variant Frontotemporal Dementia CaregiversCompletedNCT04686266Not applicableResults posted
- Rural Dementia Caregiver ProjectCompletedNCT04428112Not applicableResults posted
- Care of Persons With Dementia in Their Environments (COPE) in Programs of All-Inclusive Care of the Elderly (PACE)CompletedNCT04165213Not applicableResults posted
- Intranasal Insulin in Frontotemporal Dementia (FTD)TerminatedNCT04115384Phase 2Results posted
- Alzheimer's PET Imaging in Racially/Ethnically Diverse AdultsCompletedNCT03706261Phase 1Results posted
- Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer's Disease and Frontotemporal DementiaCompletedNCT03422250Not applicableResults posted
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's DiseaseCompletedNCT03186989Phase 1Results posted
- Lithium As a Treatment to Prevent Impairment of Cognition in EldersCompletedNCT03185208Phase 4Results posted
- A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's DiseaseCompletedNCT02880956Phase 2Results posted
- Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal DementiaCompletedNCT02736695Phase 1Results posted
- Tau Imaging of Chronic Traumatic EncephalopathyCompletedNCT02191267Phase 2Results posted
- Therapy in Amyotrophic Lateral Sclerosis (TAME)CompletedNCT02118727Phase 2Results posted
- A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal DegenerationCompletedNCT00703677Phase 1/2Results posted
- Biology-Driven Cognitive Profiling in Huntington's DiseaseActive, not recruitingNCT07503743
- First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the BrainCompletedNCT07348276Early Phase 1
- ETASCAI Pilot ProjectCompletedNCT06790849Not applicable
- Family Caregiver Online Survey (Dementia and Swallowing Difficulties)CompletedNCT06471660
- SAMi Intervention Study to Evaluate Smartwatch Interventions in Persons With MCI and DementiaCompletedNCT05885620Not applicable
- Nabilone for Agitation in Frontotemporal DementiaTerminatedNCT05742698Phase 2
- Tau PET Imaging in Opioid Use DisorderCompletedNCT05651516Early Phase 1
- A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy ParticipantsActive, not recruitingNCT05344989Phase 1
- Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)Active, not recruitingNCT05331144Phase 2
- A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's DiseaseStatus unknownNCT05326009
- Tau Protein and SV2a Imaging in Patients With Tau Protein-related DiseasesStatus unknownNCT05260151
- Dopaminergic Therapy for Frontotemporal Dementia PatientsCompletedNCT04937452Phase 2
- tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility StudyWithdrawnNCT04883229Not applicable
- ECOCAPTURE for the Assessment of Apathy Under Real-life ConditionsCompletedNCT04865172
- Deep Brain Stimulation in Alzheimer's Disease: Biomarkers and Dose OptimizationCompletedNCT04856072Not applicable
- Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept StudyActive, not recruitingNCT04828434Not applicable
- A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 GenesTerminatedNCT04747431Phase 1/2
- Spaced Retrieval as Treatment for AphasiaCompletedNCT04623125Not applicable
- Establishing 18F PMPBB3 (APN 1607) PET Imaging Markers for Diagnosis of Tauopathy Parkinsonism SyndromesCompletedNCT04557865Not applicable
- Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear PalsyCompletedNCT04539041Phase 1
- University of Washington Alzheimer's Disease Research Center (UW ADRC) Imaging & Biomarker CoreStatus unknownNCT04437290
- FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and ADWithdrawnNCT04311281
- Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's DiseaseStatus unknownNCT04271163Phase 1/2
- Association of Plasma Biomarkers for Neurological Injury and Postoperative Delirium After Cardiac SurgeryCompletedNCT04194411
- Voices Of Individuals: Challenges and Experiences Of bvFTDCompletedNCT04060082
- Blod Biomarkers for StrokeStatus unknownNCT03941249
- CNS Tau Kinetics in Healthy Aging and Alzheimer's DiseaseCompletedNCT03938870
- Estimate of the TSD Based on the Quantification of the Tau Protein in CSFStatus unknownNCT03845439
- BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TESTerminatedNCT03658135Phase 1
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolActive, not recruitingNCT03507257
- Retinal Nerve Fiber Layer Thickness and Cerebrospinal Fluid Aβ/TauCompletedNCT03447613
- Ectosomes, New Biomarkers of Tau Pathology?CompletedNCT03381482
- A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive AphasiaStatus unknownNCT03174886Phase 1
- A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's DiseaseCompletedNCT03112096Phase 1
- 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2CompletedNCT02966145
- tDCS Effect on Cognitive Functions From Patients With Alzheimer's Disease or Progressive Primary AphasiaStatus unknownNCT02873546Not applicable
- Alzheimer's Disease Neuroimaging Initiative 3CompletedNCT02854033
- 18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN StudyCompletedNCT02850146Phase 1
- [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative DiseaseCompletedNCT02656498Phase 2
- 24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's DiseaseCompletedNCT02579252Phase 2
- Characterisation of Primary Progressives AphasiasStatus unknownNCT02297035Not applicable
- Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's DiseaseCompletedNCT02243982Early Phase 1
- Down Syndrome Biomarker Initiative (DSBI)CompletedNCT02141971
- Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy SubjectsCompletedNCT02103894Phase 1
- 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's DiseaseCompletedNCT02031198Phase 1
- 4 Repeat Tauopathy Neuroimaging InitiativeCompletedNCT01804452
- A Study of Brain Aging in Vietnam War VeteransCompletedNCT01687153
- Safety Study of Intranasal Oxytocin in Frontotemporal DementiaCompletedNCT01386333Phase 1
- Alzheimer's Disease Neuroimaging Initiative 2CompletedNCT01231971
- Oxytocin and Social Cognition in Frontotemporal DementiaCompletedNCT01002300Not applicable
- Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal DementiaStatus unknownNCT00674960Phase 1
- Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal DementiaCompletedNCT00594737Phase 3
- Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal FluidCompletedNCT00439166Phase 3
- Amyloid Plaque and Tangle Imaging in Aging and DementiaCompletedNCT00355498